Parasitic diseases: Investigating the epidemiology, pathogenesis, and control measures of parasitic infections, including those caused by protozoa and helminths.
Host-parasite interactions: Exploring the mechanisms of host immune response to parasitic infections, including the role of cytokines, chemokines, and immune cells in parasite clearance or persistence.
Molecular parasitology: Studying the genetic diversity, molecular epidemiology, and drug resistance mechanisms of parasitic pathogens using molecular techniques such as PCR, sequencing, and bioinformatics analysis.
Parasite diagnostics: Developing and optimizing molecular, serological, and immunological diagnostic methods for the detection and identification of parasitic infections, aiming for accurate and rapid diagnosis.
Therapeutics and drug discovery: Investigating novel therapeutic targets, drug candidates, and treatment strategies for parasitic diseases, including the evaluation of drug efficacy, toxicity, and resistance profiles.
Immunoparasitology: Understanding the immunological mechanisms underlying host susceptibility or resistance to parasitic infections, with a focus on identifying biomarkers of infection and immune protection.
Public health implications: Assessing the impact of parasitic diseases on public health, socioeconomic development, and quality of life, and developing strategies for disease prevention, control, and elimination.